NATA and LifeArc have awarded £8M to a consortium led by Professor Matthew Wood, University of Oxford, to develop new methods for delivering oligonucleotide therapies.
The NAT Delivery Challenge consortium (TransNAT) aims to develop novel methodologies and platforms to target oligonucleotides more effectively to the CNS and heart and skeletal muscles.
For more information please visit: https://www.transnat.org.uk
